BioPharma Dive January 21, 2020
Parijat Sharma & Matt Ruple

A confluence of factors is driving a dramatic shift in healthcare delivery from traditional sites of care such as hospitals and clinics to outpatient and retail care sites such as urgent care clinics and ambulatory surgical centers. Of course, this shift doesn’t just change things for patients and providers. It also greatly affects the go-to-market strategies for pharmaceutical and medical device manufacturers. As the care setting evolves and diversifies, stakeholders throughout the healthcare ecosystem have to evolve in kind.

What’s Behind the Shift to Alternate Sites of Care?

As with most changes in the healthcare ecosystem, the shift to alternate sites of care is being prompted by several drivers and involves many stakeholders. Rising healthcare expenditures are prompting payers to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Health System / Hospital, Medical Devices, Pharma, Provider, Retail care, Technology, Telehealth, Urgent care
Kansas health systems announces partnership to improve care
Under Trump, Future Of Harm Reduction Policies To Curb Drug Overdoses Is Unclear
Pulling Out the Rug on Informed Consent — New Legal Threats to Clinicians and Patients
COVID-19 Had Worst Disease Outcomes Among Respiratory Viruses
AI-Powered Digital Therapeutics Transform Neurocare for Parkinson's

Share This Article